GREENWICH LIFESCIENCES INC. - COMMON STOCK

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 

10 2 2025 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe 

29 1 2025 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland

27 1 2025 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01 

23 1 2025 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Provides Update on Commercial Manufacturing

22 1 2025 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01

14 1 2025 06:15:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France 

13 1 2025 07:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Partners with GIM in Italy

26 11 2024 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Provides Update on Corporate Events

18 11 2024 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain

01 8 2024 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Set to Join Russell 2000 Index Again

26 6 2024 07:33:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Announces $2.5 Million Private Placement

14 6 2024 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

13 3 2024 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

12 3 2024 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries

27 2 2024 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

22 2 2024 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

14 2 2024 06:00:00 提供 Nasdaq GlobeNewswire

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024

21 11 2023 06:00:00 提供 Nasdaq GlobeNewswire